Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Check Cap Ltd (CHEK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Check Cap Ltd's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.2900 +0.0300    +1.33%
23/04 - Closed. Currency in USD ( Disclaimer )
After Hours
2.4500
+0.1600
+6.9869%
18:03:10 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 14,884
  • Bid/Ask: 2.2900 / 2.5800
  • Day's Range: 2.2100 - 2.2900
Check Cap Ltd 2.2900 +0.0300 +1.33%

CHEK Recent Sentiments

 
This page contains information on users’ sentiments for the Check Cap Ltd stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Apr 04, 2024 Felix Salan De Castro   2.5500 Apr 08, 2024 @ 2.5761 +1.02%
Apr 04, 2024 Wenceslao Garcia...   2.7900 Apr 08, 2024 @ 2.5761 -7.67%
Mar 28, 2024 João Cazalta   2.9700 Apr 19, 2024 @ 2.2600 -23.91%
Mar 27, 2024 dulat niyazov   2.7300 Apr 19, 2024 @ 2.2600 -17.22%
Mar 27, 2024 Serg Lebedev   2.4800 Apr 19, 2024 @ 2.2600 -8.87%
Mar 26, 2024 Maurice Cereghini   2.5101 Apr 19, 2024 @ 2.2600 -9.96%
Mar 26, 2024 Robbert Kuipers   2.4260 Apr 19, 2024 @ 2.2600 -6.84%
Mar 26, 2024 Robbert Kuipers   2.4260 Mar 26, 2024 @ 2.4260 0.00%
Mar 26, 2024 Luis Benitez   2.6700 Apr 01, 2024 @ 2.7200 +1.87%
Mar 08, 2024 Ymer franca   1.0000 Mar 08, 2024 @ 1.8700 +87.00%
Mar 07, 2024 Maurice Cereghini   1.9000 Mar 29, 2024 @ 3.1100 +63.68%
Jan 19, 2024 Maurice Cereghini   2.0600 Feb 09, 2024 @ 2.2200 +7.77%
Jan 18, 2024 Marco Stengs   2.1016 Feb 09, 2024 @ 2.2200 +5.63%
Jan 10, 2024 Paulo Antunes   2.2100 Feb 02, 2024 @ 2.1300 -3.62%
Jan 02, 2024 Orhan Rençber   2.1000 Jan 26, 2024 @ 2.1900 +4.29%
Oct 25, 2023 René Cardona   3.2800 Nov 30, 2023 @ 2.9200 -10.98%
Oct 04, 2023 재근 임   3.7400 Nov 30, 2023 @ 2.9200 +21.93%
Sep 05, 2023 Fernando Miguez   3.0619 Nov 30, 2023 @ 2.9200 -4.63%
Aug 08, 2023 Rustem Shabanaliev   3.7400 Nov 30, 2023 @ 2.9200 +21.93%
Jul 25, 2023 Joel Moses   3.1450 Nov 30, 2023 @ 2.9200 -7.15%
Jul 14, 2023 Gianluigi Martone   2.8123 Nov 30, 2023 @ 2.9200 +3.83%
Jun 07, 2023 Maurice Cereghini   2.3250 Nov 30, 2023 @ 2.9200 +25.59%
Jun 07, 2023 jyotsna singhal   2.2901 Nov 30, 2023 @ 2.9200 +27.51%
Jun 06, 2023 Maurice Cereghini   1.8500 Nov 30, 2023 @ 2.9200 +57.84%
May 26, 2023 Rodrigo Novak   1.4900 May 31, 2023 @ 1.4800 -0.67%
May 11, 2023 solomon gentilini   1.7200 Nov 30, 2023 @ 2.9200 -69.77%
May 10, 2023 dulat niyazov   1.8500 Nov 30, 2023 @ 2.9200 +57.84%
May 10, 2023 Lord of Money   1.9100 Nov 30, 2023 @ 2.9200 +52.88%
May 10, 2023 Robbert Kuipers   1.9000 Nov 30, 2023 @ 2.9200 +53.68%
May 10, 2023 Robbert Kuipers   1.9000 May 10, 2023 @ 1.9000 0.00%
May 10, 2023 Tanguy Meert   2.1100 Nov 30, 2023 @ 2.9200 +38.39%
May 10, 2023 רונן בן חמו   1.7799 Nov 30, 2023 @ 2.9200 +64.05%
May 10, 2023 Lucas Haefliger   1.7300 Nov 30, 2023 @ 2.9200 +68.79%
Apr 12, 2023 Fernando Miguez   1.3700 May 09, 2023 @ 1.3986 +2.09%
Apr 12, 2023 jyotsna singhal   1.3700 May 09, 2023 @ 1.3986 +2.09%
Apr 04, 2023 dulat niyazov   1.2600 May 09, 2023 @ 1.3986 +11.00%
Mar 29, 2023 Jan Albert Jongkees   1.4600 Apr 21, 2023 @ 1.3900 -4.79%
Mar 24, 2023 Grzegorz Lis   1.2200 Apr 14, 2023 @ 1.3400 +9.84%
Mar 23, 2023 Maurice Cereghini   1.2905 Apr 14, 2023 @ 1.3400 +3.84%
Mar 21, 2023 Clayton Neto   1.7600 Apr 14, 2023 @ 1.3400 -23.86%
Mar 21, 2023 Maurice Cereghini   1.7250 Apr 14, 2023 @ 1.3400 -22.32%
Mar 21, 2023 חן אליאני   1.7700 Apr 14, 2023 @ 1.3400 -24.29%
Mar 14, 2023 Валерий Юрьевич   3.0300 Mar 20, 2023 @ 2.9550 -2.48%
Feb 23, 2023 Israel Winer   3.2700 Mar 17, 2023 @ 2.9100 +11.01%
Feb 21, 2023 Jonathan Daphna   3.2800 Mar 17, 2023 @ 2.9100 -11.28%
Feb 14, 2023 Maurice Cereghini   3.5800 Mar 10, 2023 @ 2.9800 -16.76%
Feb 10, 2023 Amiram Abergel   4.0899 Feb 13, 2023 @ 3.5899 +12.23%
Feb 09, 2023 Maurice Cereghini   4.4000 Mar 03, 2023 @ 3.2600 -25.91%
Feb 09, 2023 Lucas Haefliger   4.3292 Mar 03, 2023 @ 3.2600 -24.70%
Feb 07, 2023 동현 김   4.6847 Mar 03, 2023 @ 3.2600 -30.41%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CHEK Comments

Write your thoughts about Check Cap Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
jyotsna singhal
jyotsna singhal Nov 28, 2022 3:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What’s going on really 🥹🥹🥹
Vladimir Ivanov
Vladimir Ivanov Aug 29, 2022 3:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$10 in few weeks! (after r/s)
Vladimir Ivanov
Vladimir Ivanov Jun 21, 2022 8:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
today is the day!
Sandeep Karwa
Sandeep Karwa Jun 21, 2022 8:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is the good news ?
yesyes yes yes yes
yesyes yes yes yes Apr 21, 2022 7:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is an easy $2.50 stock on trials ending
Vincent Ornells
Vincent Ornells Apr 01, 2022 1:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Clinical trials begin April 15th 2022
Sandeep Karwa
Sandeep Karwa Apr 01, 2022 1:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How is the outlook short and long term ?
DEMOLITION MIND
DEMOLITION MIND Feb 07, 2022 10:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fda approval of pivotal study!!!
DEMOLITION MIND
DEMOLITION MIND Feb 01, 2022 8:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
We may see the moon soon
DEMOLITION MIND
DEMOLITION MIND Dec 09, 2021 3:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Countdown..
DEMOLITION MIND
DEMOLITION MIND Dec 03, 2021 4:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Com’oooon maaan!!!!
DEMOLITION MIND
DEMOLITION MIND Nov 25, 2021 2:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
For those new to Check Cap Here are some key pointsCheck Cap's C-Scan pill for colonoscopy has been approved for use in Isreal since 2018. https://www.prnewswire.com/news-releases/check-cap-receives-approval-from-the-israeli-ministry-of-health-to-initiate-commercial-sales-in-israel-of-its-c-scan-system-300706973.htmlCheck Cap's Scan tech requires no preparatory procedure which makes follow through with the procedure much easier and less impactful to individual's lives. Patients do not have to experience pain and discomfort from procedure like they do colonoscopies. They also do not need the same facility use as a colonoscopy allowing people to save time.The FDA is particularly interested in Chek because roughly 40% of Americans who should get a colonoscopies don't. Existing non-invasive colon screening is less acurate than C-scan Tech used by Check Cap.Recent study https://www.businesswire.com/news/home/20150428006203/en/New-Study-Reveals-People-Avoid-Colonoscopy
DEMOLITION MIND
DEMOLITION MIND Nov 25, 2021 2:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
28 percent do not feel it is necessary20.1 percent say it’s too expensive20.1 percent dislike the procedure itself (addressed by Check Cap)15.8 percent rely on other methods to avoid colon cancer (addressed by Check Cap)6.5 percent do not know they are supposed to get one6.5 percent are too busy with other priorities (addressed by Check Cap)Additionally Chek has already raised a large amount of capitolthis year that it expects will carry it through a stage 3 study for the US. Simplywall.st reports they should have enough capitol for 3 years of funding, but this does not account for large scale studies like a phase II and III trial. Covid delayed C-Scan US clinical testing as the FDA was unable to get to Israel in order to inspect the facility.Covid also highlighted challenges to Check Cap's supply chain as they previously used a single supplier, this is something management has been addressing and they have expressed confidence that their expansion and supply chain changes wi
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email